Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma

Chest

Volumn 132, Issue 1, 2007, Pages 120-126

  Polonikov, Alexey V ^a   Ivanov, Vladimir P ^a   Solodilova, Mariya A ^a   Khoroshaya, Irina V ^a   Kozhuhov, Mikhail A ^b   Panfilov, Valery I ^b  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Kursk Regional Clinical Hospital   (Russian Federation)

Author keywords

Arachidonic acids metabolism; Asthma; Case control studies; Cytochrome p 450 CYP2J2 genetics; Single nucleotide polymorphism

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450 2J2; CYTOCHROME P450 ISOENZYME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; CASE CONTROL STUDY; CONTROLLED STUDY; CYP2J2 GENE; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROMOTER REGION; RUSSIAN FEDERATION;

EID: 34447543109     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0371     Document Type: Article

References (26)

1. McFadden ER Jr, Gilbert IA. Asthma. N Engl J Med 1992; 327:1928-1937
2. Sheffer AL. Management of the adult asthma patient. Allergy Proc 1995; 16:1-4
3. Cookson WOCM. The genetics of asthma. In: Berg K, Boulyjenkow V, Christen Y, eds. Genetic approaches to non-communicable disease. Berlin, Germany: Springer-Verlag, 1996; 79-96
4. Sayers I, Barton S, Rorke S, et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003; 33:1103-1110
5. Choi JH, Park HS, Oh HB, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004; 114:337-344
6. Shi J, Misso NL, Duffy DL, et al. Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy. Eur Respir J 2005; 26:249-256
7. Kim SH, Bae JS, Suh CH, et al. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy 2005; 60:760-765
8. Sanak M, Szczeklik W, Szczeklik A. Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. J Allergy Clin Immunol 2005; 116:221-223
9. Holtzman MJ. Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am Rev Respir Dis 1991; 143:188-203
10. Jacobs ER, Zeldin DC. The lung HETEs (and EETs) up. Am J Physiol Heart Circ Physiol 2001; 280:1-10
11. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82:131-185
12. McGiff JC. Cytochrome P450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 1991; 31:339-369
13. Wu S, Moomaw CR, Tomer KB, et al. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996; 271:3460-3468
14. Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999; 285:1276-1279
15. Zeldin DC, Moomaw CR, Jesse N, et al. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 1996; 330:87-96
16. Zeldin DC, Foley J, Goldsworthy SM, et al. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol 1997; 51:931-943
17. Zeldin DC, Foley J, Ma J, et al. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 1996; 50:1111-1117
18. Scarborough PE, Ma J, Qu W, et al. P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 1999; 31:205-234
19. King LM, Ma J, Srettabunjong S, et al. Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol Pharmacol 2002; 61:840-852
20. Spiecker M, Darius H, Hankeln T, et al. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 2004; 110: 2132-2136
21. Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6:1-42
22. Hukkanen J, Pelkonen O, Hakkola J, et al. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002; 32:391-411
23. Nelson DR. Cytochrome P450 and the individuality of species. Arch Biochem Biophys 1999; 369:1-10
24. Ca channels. Am J Physiol Lung Cell Mol Physiol 1998; 275:423-431
25. Zhu D, Falck JR, Bousamra M, et al. Cytochrome P450 isoforms are present in airway microsomes and P450 metabolites modulate human bronchial tone [abstract]. Am J Respir Crit Care Med 2000; 161:P695
26. Hwang TC, Guggino SE, Guggino WB. Direct modulation of secretory chloride channels by arachidonic and other cis unsaturated fatty acids. Proc Natl Acad Sci U S A 1990; 87:5706-5709